ClinicalTrials.gov
public full text
Public Domain
HER2 Expression of CTC to Predict Response in HER2-positive Advanced Breast Cancer Patients Treated With ADC
To evaluate the predictive and prognostic value of HER2 expression of circulating tumor cells in HER2-positive advanced breast cancer patients treated with ADC
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC#806649
- Real-World Treatment of ADC-Resistant HER2-Low Advanced Breast Cancer#366617
- Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma#123473
- Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients#894566
- Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer#869438
Record · ID 838847
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive